In addition, DFS results showed that in ACC (HR = 3.5, p = 0.00039), LIHC (HR = 1.7, p = 0.00096), UVM (HR = 2.8, p = 0.032), KIRP (HR = 1.9, p = 0.034), MESO (HR = 1.8, p = 0.038), and PRAD (HR = 1.8, p = 0.005), low RBM10 level was positively linked with better DFS but negatively linked with better DFS in GBM patients (HR = 0.62, p = 0.02, Figure 2(b)). The gene discussed is RBM10; the disease is glioblastoma.